Education
BS, University of California, Irvine, 1977
MS, Georgetown University, 1978
MD, Georgetown University, 1982
Biography
Currently the chief of endocrinology at the VAMC, Washington, DC
Research
Current research projects
- Endothelial progenitor and adipocyte stem cell changes with exercise in prediabetes
- Procalcitonin and adrenomedullin biomarker studies to reduce antibiotic use
- Procalcitonin-Ab studies to attenuate sepsis
- Industry sponsored trial of SGLT2
Grants
- NIH-ACCORD
- NIAID- 1R01AI079446-01 (Co-PI)
- ELIXA (www.clinicaltrials.gov no. NCT01147250)(Co-PI) 2010 IADR/AADR William J. Gies Award for Clinical Research
Teaching
- MED 373
Centers and Institutes
- VAMC
- USUHS, Bethesda
Publications
Pleural fluid procalcitonin to distinguish infectious from noninfectious etiologies of pleural effusions. Khosla R, Khosla SG, Becker KL, Nylen ES. J Hosp Med. 2016 May;11(5):363-5
Salivary and serum procalcitonin and C-reactive protein as biomarkers of periodontitis in United States veterans with osteoarthritis or rheumatoid arthritis. Redman RS, Kerr GS, Payne JB, Mikuls TR, Huang J, Sayles HR, Becker KL, Nylén ES. Biotech Histochem. 2016;91(2):77-85
Passi M, Garige M, Gong M, Leckey L, Nylen ES, Shah R, Lakshman MR. Protective roles of polyphenols against the pathogenesis of diabetes, cardiovascular and other chronic diseases. Curr Topics Biochemical Res 2014;15:109-126
Papademetriou V, Lovato L, Doumas M, Nylen E, Mottl A, Cohen RM, Applegate WB, Puntakee Z, Yale JF, Cushman WC. Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes. Kidney Int. 2014 Sep 17.
Panico C, Nylen E. Procalcitonin beyond the acute phase: BMC Med. 2013;11:189
Nylen ES, Faselis C, Kheirbek R, Myers J, Panagiotakos D, Kokkinos P. Statins modulate the mortality risk associated with obesity and cardiorespiratory fitness in diabetics. J Clin Endocrinol Metab. 2013;98:3394-401
Kokkinos P, Myers J, Nylen E, Panagiotakos DB, Manolis A, Pittaras A, Blackman MR, Jacob-Issac R,Faselis C, Abella J, Singh S. Exercise capacity and all-cause mortality in african american and caucasian men with type 2 diabetes. Diabetes Care. 2009;32:623-8
Nylen ES, Kokkinos P, Myers J, Faselis C. Prognostic effect of exercise capacity on mortality in older adults with diabetes mellitus. J Am Geriatr Soc. 2010;58:1850-4.
Nylen ES, Kokkinos P, Myers J, Faselis C. Prognostic effect of exercise capacity on mortality in older adults with diabetes mellitus. J Am Geriatr Soc. 2010;58:1850-4.
Nylén ES, Faselis C, Kheirbek R, Myers J, Panagiotakos D, Kokkinos P. Statins modulate the mortality risk associated with obesity and cardiorespiratory fitness in diabetics. J Clin Endocrinol Metab. 2013 Aug;98:3394-401.
Papademetriou V, Lovato L, Doumas M, Nylen E, Mottl A, Cohen RM, Applegate WB, Puntakee Z, Yale JF, Cushman WC; ACCORD Study Group. Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes. Kidney Int. 2015;87:649-59
Nylen ES, Gandhi SM, Kheirbek R, Kokkinos P. Treatment Enhanced fitness and renal function in Type 2 diabetes. Diabet Med. 2015;32:1342-5
Passi M, Garige M, Gong M, Leckey L, Nylen ES, Shah R, Lakshman MR. Protective roles of polyphenols against the pathogenesis of diabetes, cardiovascular and other chronic diseases. Curr Topics Biochemical Res 2014;15:109-126
Papademetriou V, Lovato L, Doumas M, Nylen E, Mottl A, Cohen RM, Applegate WB, Puntakee Z, Yale JF, Cushman WC. Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes. Kidney Int. 2014 Sep 17.
Panico C, Nylen E. Procalcitonin beyond the acute phase: BMC Med. 2013;11:189
Nylen ES, Faselis C, Kheirbek R, Myers J, Panagiotakos D, Kokkinos P. Statins modulate the mortality risk associated with obesity and cardiorespiratory fitness in diabetics. J Clin Endocrinol Metab. 2013;98:3394-401
Kokkinos P, Myers J, Nylen E, Panagiotakos DB, Manolis A, Pittaras A, Blackman MR, Jacob-Issac R,Faselis C, Abella J, Singh S. Exercise capacity and all-cause mortality in african american and caucasian men with type 2 diabetes. Diabetes Care. 2009;32:623-8
Nylen ES, Kokkinos P, Myers J, Faselis C. Prognostic effect of exercise capacity on mortality in older adults with diabetes mellitus. J Am Geriatr Soc. 2010;58:1850-4.
Nylen ES, Kokkinos P, Myers J, Faselis C. Prognostic effect of exercise capacity on mortality in older adults with diabetes mellitus. J Am Geriatr Soc. 2010;58:1850-4.
Nylén ES, Faselis C, Kheirbek R, Myers J, Panagiotakos D, Kokkinos P. Statins modulate the mortality risk associated with obesity and cardiorespiratory fitness in diabetics. J Clin Endocrinol Metab. 2013 Aug;98:3394-401.
Papademetriou V, Lovato L, Doumas M, Nylen E, Mottl A, Cohen RM, Applegate WB, Puntakee Z, Yale JF, Cushman WC; ACCORD Study Group. Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes. Kidney Int. 2015;87:649-59
Nylen ES, Gandhi SM, Kheirbek R, Kokkinos P. Treatment Enhanced fitness and renal function in Type 2 diabetes. Diabet Med. 2015;32:1342-5